{"transactions":[{"id":3612710,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159482,"kind":"person","name":"McGrane Nicholas","position":1,"cik":"0001643086","reported_name":"McGrane Nicholas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock Option (right to buy)","published_at":"2019-03-05T16:50:46.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":57741,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Securities vest at a rate of 25% annually beginning March 1, 2020."}],"balance_after":57741,"derivative":{"exercise_price":13.29,"expiration_date":"2029-03-01","underlying":"Class A Common Stock","underlying_shares":57741},"source":{"system":"sec-edgar","filing":"0001628908-19-000010","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1643086/000162890819000010/primary_doc.xml","form_type":"4"}},{"id":3612709,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159482,"kind":"person","name":"McGrane Nicholas","position":1,"cik":"0001643086","reported_name":"McGrane Nicholas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2019-03-05T16:50:46.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":30098,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units granted to Mr. McGrane pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"Securities vest at a rate of 25% annually beginning March 1, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":84088,"source":{"system":"sec-edgar","filing":"0001628908-19-000010","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643086/000162890819000010/primary_doc.xml","form_type":"4"}},{"id":4076373,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159482,"kind":"person","name":"McGrane Nicholas","position":1,"cik":"0001643086","reported_name":"McGrane Nicholas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock Option (right to buy)","published_at":"2018-02-05T17:13:03.000Z","date":"2018-02-01","kind":"grant","acquired":true,"shares":52609,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Securities vest at a rate of 25% annually beginning February 1, 2019."}],"balance_after":52609,"derivative":{"exercise_price":13.95,"expiration_date":"2028-02-01","underlying":"Class A Common Stock","underlying_shares":52609},"source":{"system":"sec-edgar","filing":"0001628908-18-000005","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1643086/000162890818000005/primary_doc.xml","form_type":"4"}},{"id":4076372,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159482,"kind":"person","name":"McGrane Nicholas","position":1,"cik":"0001643086","reported_name":"McGrane Nicholas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2018-02-05T17:13:03.000Z","date":"2018-02-01","kind":"grant","acquired":true,"shares":22401,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units granted to Mr. McGrane pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"Securities vest at a rate of 25% annually beginning February 1, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":53990,"source":{"system":"sec-edgar","filing":"0001628908-18-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643086/000162890818000005/primary_doc.xml","form_type":"4"}},{"id":4258420,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159482,"kind":"person","name":"McGrane Nicholas","position":1,"cik":"0001643086","reported_name":"McGrane Nicholas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock Option (right to buy)","published_at":"2017-07-12T17:14:50.000Z","date":"2017-07-10","kind":"exercise","acquired":false,"shares":1667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on September 14, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Class A Common Stock Options exercised vested on February 1, 2016."}],"balance_after":209618,"derivative":{"exercise_price":3.84,"expiration_date":"2024-10-22","underlying":"Class A Common Stock","underlying_shares":1667},"source":{"system":"sec-edgar","filing":"0001628908-17-000036","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1643086/000162890817000036/primary_doc.xml","form_type":"4"}},{"id":4258419,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159482,"kind":"person","name":"McGrane Nicholas","position":1,"cik":"0001643086","reported_name":"McGrane Nicholas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2017-07-12T17:14:50.000Z","date":"2017-07-10","kind":"sale","acquired":false,"shares":1667,"price":25.42,"value":42375.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on September 14, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $25.25-$25.55, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":31589,"source":{"system":"sec-edgar","filing":"0001628908-17-000036","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1643086/000162890817000036/primary_doc.xml","form_type":"4"}},{"id":4258418,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159482,"kind":"person","name":"McGrane Nicholas","position":1,"cik":"0001643086","reported_name":"McGrane Nicholas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2017-07-12T17:14:50.000Z","date":"2017-07-10","kind":"exercise","acquired":true,"shares":1667,"price":3.84,"value":6401.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on September 14, 2016."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":33256,"source":{"system":"sec-edgar","filing":"0001628908-17-000036","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643086/000162890817000036/primary_doc.xml","form_type":"4"}},{"id":4282312,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159482,"kind":"person","name":"McGrane Nicholas","position":1,"cik":"0001643086","reported_name":"McGrane Nicholas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock Option (right to buy)","published_at":"2017-06-14T17:32:11.000Z","date":"2017-06-12","kind":"exercise","acquired":false,"shares":1667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Class A Common Stock Options exercised vested on February 1, 2016."}],"balance_after":211285,"derivative":{"exercise_price":3.84,"expiration_date":"2024-10-22","underlying":"Class A Common Stock","underlying_shares":1667},"source":{"system":"sec-edgar","filing":"0001628908-17-000032","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1643086/000162890817000032/primary_doc.xml","form_type":"4"}},{"id":4282311,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159482,"kind":"person","name":"McGrane Nicholas","position":1,"cik":"0001643086","reported_name":"McGrane Nicholas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2017-06-14T17:32:11.000Z","date":"2017-06-12","kind":"sale","acquired":false,"shares":100,"price":25.4,"value":2540.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":31589,"source":{"system":"sec-edgar","filing":"0001628908-17-000032","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1643086/000162890817000032/primary_doc.xml","form_type":"4"}},{"id":4282310,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159482,"kind":"person","name":"McGrane Nicholas","position":1,"cik":"0001643086","reported_name":"McGrane Nicholas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2017-06-14T17:32:11.000Z","date":"2017-06-12","kind":"sale","acquired":false,"shares":1567,"price":24.53,"value":38438.51,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported on Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $24.05-$24.85, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":31689,"source":{"system":"sec-edgar","filing":"0001628908-17-000032","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1643086/000162890817000032/primary_doc.xml","form_type":"4"}},{"id":4282309,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159482,"kind":"person","name":"McGrane Nicholas","position":1,"cik":"0001643086","reported_name":"McGrane Nicholas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2017-06-14T17:32:11.000Z","date":"2017-06-12","kind":"exercise","acquired":true,"shares":1667,"price":3.84,"value":6401.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":33256,"source":{"system":"sec-edgar","filing":"0001628908-17-000032","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643086/000162890817000032/primary_doc.xml","form_type":"4"}},{"id":4288469,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159482,"kind":"person","name":"McGrane Nicholas","position":1,"cik":"0001643086","reported_name":"McGrane Nicholas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock Option (right to buy)","published_at":"2017-06-08T16:38:59.000Z","date":"2017-06-07","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Class A Common Stock Options exercised vested on February 1, 2016."}],"balance_after":212952,"derivative":{"exercise_price":3.84,"expiration_date":"2024-10-22","underlying":"Class A Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001643086-17-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1643086/000164308617000004/primary_doc.xml","form_type":"4"}},{"id":4288468,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159482,"kind":"person","name":"McGrane Nicholas","position":1,"cik":"0001643086","reported_name":"McGrane Nicholas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2017-06-08T16:38:59.000Z","date":"2017-06-07","kind":"sale","acquired":false,"shares":10000,"price":27.01,"value":270100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $27.00-$27.025, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":31589,"source":{"system":"sec-edgar","filing":"0001643086-17-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1643086/000164308617000004/primary_doc.xml","form_type":"4"}},{"id":4288467,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159482,"kind":"person","name":"McGrane Nicholas","position":1,"cik":"0001643086","reported_name":"McGrane Nicholas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2017-06-08T16:38:59.000Z","date":"2017-06-07","kind":"exercise","acquired":true,"shares":10000,"price":3.84,"value":38400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":41589,"source":{"system":"sec-edgar","filing":"0001643086-17-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1643086/000164308617000004/primary_doc.xml","form_type":"4"}},{"id":4288466,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159482,"kind":"person","name":"McGrane Nicholas","position":1,"cik":"0001643086","reported_name":"McGrane Nicholas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2017-06-08T16:38:59.000Z","date":"2017-06-06","kind":"sale","acquired":false,"shares":495,"price":25.75,"value":12746.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":31589,"source":{"system":"sec-edgar","filing":"0001643086-17-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643086/000164308617000004/primary_doc.xml","form_type":"4"}},{"id":4308284,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159482,"kind":"person","name":"McGrane Nicholas","position":1,"cik":"0001643086","reported_name":"McGrane Nicholas","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock Option (right to buy)","published_at":"2017-05-23T18:21:31.000Z","date":"2017-05-19","kind":"exercise","acquired":false,"shares":47508,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Class A Common Stock Options exercised vested on November 1, 2015."}],"balance_after":222952,"derivative":{"exercise_price":3.84,"expiration_date":"2024-04-01","underlying":"Class A Common Stock","underlying_shares":47508},"source":{"system":"sec-edgar","filing":"0000950157-17-000719","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1643086/000095015717000719/form4.xml","form_type":"4"}},{"id":4308283,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159482,"kind":"person","name":"McGrane Nicholas","position":1,"cik":"0001643086","reported_name":"McGrane Nicholas","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2017-05-23T18:21:31.000Z","date":"2017-05-19","kind":"sale","acquired":false,"shares":47508,"price":24.3,"value":1154444.4,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":32084,"source":{"system":"sec-edgar","filing":"0000950157-17-000719","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1643086/000095015717000719/form4.xml","form_type":"4"}},{"id":4308282,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159482,"kind":"person","name":"McGrane Nicholas","position":1,"cik":"0001643086","reported_name":"McGrane Nicholas","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2017-05-23T18:21:31.000Z","date":"2017-05-19","kind":"exercise","acquired":true,"shares":47508,"price":3.84,"value":182430.72,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":79592,"source":{"system":"sec-edgar","filing":"0000950157-17-000719","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643086/000095015717000719/form4.xml","form_type":"4"}},{"id":4322766,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159482,"kind":"person","name":"McGrane Nicholas","position":1,"cik":"0001643086","reported_name":"McGrane Nicholas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Cheif Financial Officer"}}],"security":"Class A Common Stock Option (right to buy)","published_at":"2017-05-12T18:45:28.000Z","date":"2017-05-10","kind":"exercise","acquired":false,"shares":1667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Class A Common Stock exercised vested on November 1, 2015. One fourth of the Class A Common Stock Options granted to the reporting person on October 22, 2014 vested on November 1, 2015; the balance vested or vests at a rate of 6.25% as of the end of each three-month period immediately thereafter during the period beginning on October 23, 2015, the day following the first anniversary of the grant date."}],"balance_after":270460,"derivative":{"exercise_price":3.84,"expiration_date":"2024-10-22","underlying":"Class A Common Stock","underlying_shares":1667},"source":{"system":"sec-edgar","filing":"0001643086-17-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1643086/000164308617000003/primary_doc.xml","form_type":"4"}},{"id":4322765,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159482,"kind":"person","name":"McGrane Nicholas","position":1,"cik":"0001643086","reported_name":"McGrane Nicholas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Cheif Financial Officer"}}],"security":"Class A Common Stock","published_at":"2017-05-12T18:45:28.000Z","date":"2017-05-10","kind":"sale","acquired":false,"shares":1667,"price":24.28,"value":40474.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $23.90-$24.65, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":130380,"source":{"system":"sec-edgar","filing":"0001643086-17-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1643086/000164308617000003/primary_doc.xml","form_type":"4"}},{"id":4322764,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159482,"kind":"person","name":"McGrane Nicholas","position":1,"cik":"0001643086","reported_name":"McGrane Nicholas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Cheif Financial Officer"}}],"security":"Class A Common Stock","published_at":"2017-05-12T18:45:28.000Z","date":"2017-05-10","kind":"exercise","acquired":true,"shares":1667,"price":3.84,"value":6401.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016."}],"balance_after":132047,"source":{"system":"sec-edgar","filing":"0001643086-17-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643086/000164308617000003/primary_doc.xml","form_type":"4"}},{"id":4347716,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159482,"kind":"person","name":"McGrane Nicholas","position":1,"cik":"0001643086","reported_name":"McGrane Nicholas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock Option (right to buy)","published_at":"2017-04-21T16:26:04.000Z","date":"2017-04-19","kind":"exercise","acquired":false,"shares":1667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Class A Common Stock Options exercised vested on November 1, 2015. One fourth of the Class A Common Stock Options granted to the reporting person on October 22, 2014 vested on November 1, 2015; the balance vested or vests at a rate of 6.25% as of the end of each three-month period immediately thereafter during the period beginning on October 23, 2015, the day following the first anniversary of the grant date."}],"balance_after":272127,"derivative":{"exercise_price":3.84,"expiration_date":"2024-10-22","underlying":"Class A Common Stock","underlying_shares":1667},"source":{"system":"sec-edgar","filing":"0001643086-17-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1643086/000164308617000002/primary_doc.xml","form_type":"4"}},{"id":4347715,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159482,"kind":"person","name":"McGrane Nicholas","position":1,"cik":"0001643086","reported_name":"McGrane Nicholas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2017-04-21T16:26:04.000Z","date":"2017-04-19","kind":"sale","acquired":false,"shares":1667,"price":22.52,"value":37540.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $22.50-22.525, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":130380,"source":{"system":"sec-edgar","filing":"0001643086-17-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1643086/000164308617000002/primary_doc.xml","form_type":"4"}},{"id":4347714,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159482,"kind":"person","name":"McGrane Nicholas","position":1,"cik":"0001643086","reported_name":"McGrane Nicholas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2017-04-21T16:26:04.000Z","date":"2017-04-19","kind":"exercise","acquired":true,"shares":1667,"price":3.84,"value":6401.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016."}],"balance_after":132047,"source":{"system":"sec-edgar","filing":"0001643086-17-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643086/000164308617000002/primary_doc.xml","form_type":"4"}},{"id":4371588,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159482,"kind":"person","name":"McGrane Nicholas","position":1,"cik":"0001643086","reported_name":"McGrane Nicholas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock Option (right to buy)","published_at":"2017-03-27T17:11:47.000Z","date":"2017-03-24","kind":"exercise","acquired":false,"shares":5001,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Class A Common Stock Options exercised vested on November 1, 2015. One fourth of the Class A Common Stock Options granted to the reporting person on October 22, 2014 vested on November 1, 2015; the balance vested or vests at a rate of 6.25% as of the end of each three-month period immediately thereafter during the period beginning on the day following the first anniversary of the grant date."}],"balance_after":273794,"derivative":{"exercise_price":3.84,"expiration_date":"2024-10-22","underlying":"Class A Common Stock","underlying_shares":5001},"source":{"system":"sec-edgar","filing":"0001643086-17-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1643086/000164308617000001/primary_doc.xml","form_type":"4"}},{"id":4371587,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159482,"kind":"person","name":"McGrane Nicholas","position":1,"cik":"0001643086","reported_name":"McGrane Nicholas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2017-03-27T17:11:47.000Z","date":"2017-03-24","kind":"sale","acquired":false,"shares":2033,"price":22.5,"value":45742.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016."}],"balance_after":130380,"source":{"system":"sec-edgar","filing":"0001643086-17-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1643086/000164308617000001/primary_doc.xml","form_type":"4"}},{"id":4371586,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159482,"kind":"person","name":"McGrane Nicholas","position":1,"cik":"0001643086","reported_name":"McGrane Nicholas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Clsss A Common Stock","published_at":"2017-03-27T17:11:47.000Z","date":"2017-03-24","kind":"sale","acquired":false,"shares":5001,"price":22.5,"value":112522.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in a multiple transactions, all at a price of $22.50. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each transaction covered by this footnote."}],"balance_after":132413,"source":{"system":"sec-edgar","filing":"0001643086-17-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1643086/000164308617000001/primary_doc.xml","form_type":"4"}},{"id":4371585,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159482,"kind":"person","name":"McGrane Nicholas","position":1,"cik":"0001643086","reported_name":"McGrane Nicholas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2017-03-27T17:11:47.000Z","date":"2017-03-24","kind":"exercise","acquired":true,"shares":5001,"price":3.84,"value":19203.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016."}],"balance_after":137414,"source":{"system":"sec-edgar","filing":"0001643086-17-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643086/000164308617000001/primary_doc.xml","form_type":"4"}},{"id":4468759,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159482,"kind":"person","name":"McGrane Nicholas","position":1,"cik":"0001643086","reported_name":"McGrane Nicholas","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock Option (right to buy)","published_at":"2017-02-03T19:37:23.000Z","date":"2017-02-01","kind":"grant","acquired":true,"shares":38297,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Securities vest at a rate of 25% annually beginning February 1, 2018."}],"balance_after":38297,"derivative":{"exercise_price":18.25,"expiration_date":"2027-02-01","underlying":"Class A Common Stock","underlying_shares":38297},"source":{"system":"sec-edgar","filing":"0000950157-17-000198","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1643086/000095015717000198/form4.xml","form_type":"4"}},{"id":4468758,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159482,"kind":"person","name":"McGrane Nicholas","position":1,"cik":"0001643086","reported_name":"McGrane Nicholas","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2017-02-03T19:37:23.000Z","date":"2017-02-01","kind":"grant","acquired":true,"shares":17123,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units granted to Mr. McGrane pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"Securities vest at a rate of 25% annually beginning February 1, 2018."}],"balance_after":132413,"source":{"system":"sec-edgar","filing":"0000950157-17-000198","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643086/000095015717000198/form4.xml","form_type":"4"}},{"id":4602613,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159482,"kind":"person","name":"McGrane Nicholas","position":1,"cik":"0001643086","reported_name":"McGrane Nicholas","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock Option (right to buy)","published_at":"2016-09-15T16:48:52.000Z","date":"2016-09-14","kind":"exercise","acquired":false,"shares":21205,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Class A Common Stock Options exercised vested on November 1, 2015. One fourth of the Class A Common Stock Options granted to the reporting person on October 22, 2014 vested on November 1, 2015; the balance vested or vests at a rate of 6.25% as of the end of each three-month period immediately thereafter during the period beginning on the day following the first anniversary of the grant date."}],"balance_after":278795,"derivative":{"exercise_price":3.84,"expiration_date":"2024-10-22","underlying":"Class A Common Stock","underlying_shares":21205},"source":{"system":"sec-edgar","filing":"0000950157-16-002176","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1643086/000095015716002176/form4.xml","form_type":"4"}},{"id":4602612,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159482,"kind":"person","name":"McGrane Nicholas","position":1,"cik":"0001643086","reported_name":"McGrane Nicholas","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2016-09-15T16:48:52.000Z","date":"2016-09-14","kind":"sale","acquired":false,"shares":21205,"price":21.54,"value":456755.7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price of $21.54 represents the public offering price of $22.50 per share of Class A Common Stock less the underwriters' discount of $0.96 per share."}],"balance_after":115290,"source":{"system":"sec-edgar","filing":"0000950157-16-002176","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1643086/000095015716002176/form4.xml","form_type":"4"}},{"id":4602611,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":159482,"kind":"person","name":"McGrane Nicholas","position":1,"cik":"0001643086","reported_name":"McGrane Nicholas","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2016-09-15T16:48:52.000Z","date":"2016-09-14","kind":"exercise","acquired":true,"shares":21205,"price":3.84,"value":81427.2,"ownership":{"direct":true},"balance_after":136495,"source":{"system":"sec-edgar","filing":"0000950157-16-002176","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643086/000095015716002176/form4.xml","form_type":"4"}}]}